Newsletter of MEDICA | View in browser | Deutsch | Print
Header of MEDICA Newsletter

The PCR of the future

Dear Sir or Madam,

PCR as a tool in diagnostics is now widely known because of the corona pandemic. But did you know that PCR analytics are also often utilized in life sciences? At MEDICA 2022, the Jena-based company BLINK DX presented a new PCR platform that has the potential to turn the use of the method upside down in both areas. Read more in our interview "BLINK DX: revolutionizing digital PCR".

Enjoy reading!

Timo Roth
Editorial team MEDICA-tradefair.com

Table of Contents

Interview: Digital PCR with BLINK DX
Newsletter Service
Image: Banner with the text: MEDICA Magazine – 365 days a year; Copyright: Messe Düsseldorf

SAPs4Tissue: human tissue models with customized biomaterials

LAB & DIAGNOSTICS

In a joint project of the Max Planck Institute for Polymer Research, Mainz, and the Translational Center for Regenerative Therapies at the Fraunhofer Institute for Silicate Research ISC, Würzburg, scientific principles and biomaterials for the standardized production of valid tissue models are to be developed.
read more
To top

PANDORA test could pave the way for better oral cancer detection

LAB & DIAGNOSTICS

Surrey scientists have developed a proof-of-concept test called PANDORA that was shown to be over 92% accurate at identifying patients with oral squamous cell carcinoma (OSCC). The test was also shown to be more than 80% accurate at identifying patients with pre-cancer or oral epithelial dysplasia (OED).
read more
To top

Microfluidics physics-based device to predict cancer therapy response

LAB & DIAGNOSTICS

A team of experts has designed a microfluidic device called microfluidic dynamic BH3 profiling (μDBP) that predicts the effectiveness of cancer treatment quickly and automatically.
read more
To top

BLINK DX: revolutionizing digital PCR

Interview – LAB & DIAGNOSTICS

Image: Graphic with the headline “Nanoreactors” that show the structure of a bead with annotations; Copyright: BLINK DX
The polymerase chain reaction, or PCR, plays a major role both in the diagnosis of infectious diseases and in research. Since the onset of the COVID-19 pandemic, the term has become widely known. At MEDICA 2022, the BLINK AG from Jena, Germany, presented the BLINK Beads, a technology that is bound to revolutionize the applications of PCR.
Click here for the interview
BLINK DX: revolutionizing digital PCR
Read all content from the experience world LAB & DIAGNOSTICS in the MEDICA Magazine here
To top

Patent: high-tech glasses replace guide dog

DIGITAL HEALTH

The technology of “the glasses that replace the guide dog” has just been patented in the USA. The European Union patent will follow, and it could well be introduced to the market during the course of next year.
read more
To top

Morbus Crohn: new imaging technique for effective therapy

MED TECH & DEVICES

An interdisciplinary research group at MedUni Vienna has investigated a new imaging technique that can improve the treatment of intestinal strictures from Morbus Crohn.
read more
To top

Novel technology for hollow organ tumour therapy

MED TECH & DEVICES

Ioana Slabu from the Institute of Applied Medical Technology and Benedict Bauer from the Institut für Textiltechnik of RWTH Aachen University have developed a novel technology for the therapy of hollow organ tumours, which was awarded second place in the RWTH Innovation Award.
read more
To top

Stent implants: Nimble Diagnostics closes financing round of one million euros

MED TECH & DEVICES

NIMBLE Diagnostics, a spin-off of the Germans Trias i Pujol Research Institute (IGTP), the UPC and the University of Barcelona (UB), has successfully closed a funding round led by Grow Ventures, together with Namarel Ventures and the Inveniam Group, that has secured more than one million euros.
read more
To top

Newsletter Service

You like our newsletter? Then please recommend us: Forward this newsletter or the link www.MEDICA.de/news_login_2 to your friends and colleagues.

If you have difficulties with your order, please write an e-mail to redaktion@medica.de.

To top
Legal disclaimer

Messe Düsseldorf GmbH
Messeplatz, Stockumer Kirchstr. 61
40474 Düsseldorf, Germany

Phone: +49 211 4560-01
Fax: +49 211 4560-668
www.messe-duesseldorf.de
info@messe-duesseldorf.de

County Court Düsseldorf HRB 63

Board of Managing Directors: Wolfram N. Diener (Chairman), Bernhard J. Stempfle, Erhard Wienkamp

Chairman of Supervisory Board: Mayor Dr. Stephan Keller

Messe Düsseldorf GmbH processes personal data relating to you. You can find more information - also on your rights - in the privacy policy of Messe Düsseldorf GmbH available at www.messe-duesseldorf.de/privacy. In principle, i.e. subject to legal restrictions, you may at any time object to the processing of your personal data either on the aforementioned website, via e-mail to privacy@messe-duesseldorf.de or via postal mail to Messe Düsseldorf GmbH, G2-RV, PF 101006, 40001 Düsseldorf, Germany.

Facebook X LinkedIn YouTube

Should you no longer wish to receive our newsletter, please click here.